Moreover, an in vitro study showed that TNF-α-induced inflammation in adipocytes decreased expression of FAM19A5 suggesting that a pro-inflammatory condition as it observed in NAFLD might cause downregulation of FAM19A5 [31, 32]. The gene discussed is TAFA5; the disease is metabolic dysfunction-associated steatotic liver disease.